Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-02-22 @ 4:14 AM
Study NCT ID:
NCT03924466
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2019-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Carcinoma | View |
| None | Locally Advanced Breast Cancer | View |
| None | Cancer of Pancreas | View |
| None | Solid Tumor With Intermediate or High HER2 Expression | View |
| None | Salivary Gland Cancer | View |
| None | Gastric Cancer | View |
| None | Endometrial Cancer | View |
| None | Uterine Cancer | View |
| None | Non Small Cell Lung Cancer | View |
| None | Biliary Tract Cancer | View |
| None | Cholangiocarcinoma | View |
| None | Colorectal Cancer | View |
| None | Urothelial Carcinoma | View |
| None | Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HER2 | View |